deltatrials
Terminated OBSERVATIONAL NCT02291965

Blood Samples to Identify Biomarkers of Busulfan

Optimizing Busulfan: Efficacy, Toxicity, and Pharmacometabolomics

Sponsor: Fred Hutchinson Cancer Center

Updated 22 times since 2017 Last updated: Feb 27, 2025 Started: Nov 30, 2014 Primary completion: Apr 20, 2019 Completion: Oct 7, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study terminated due to end of funding

A observational or N/A phase clinical study on Immunodeficiency and Leukemia, this trial is terminated or withdrawn. The trial is conducted by Fred Hutchinson Cancer Center and has accumulated 22 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Nov 2017 · 3 months · monthly snapshot~Nov 2017 – ~Apr 2018 · 5 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Jul 2019 · 7 months · monthly snapshot~Jul 2019 – ~Jun 2020 · 11 months · monthly snapshot~Jun 2020 – ~Nov 2020 · 5 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~May 2022 · 4 months · monthly snapshot~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~Feb 2023 · 7 months · monthly snapshot~Feb 2023 – ~Aug 2023 · 6 months · monthly snapshot~Aug 2023 – ~Mar 2024 · 7 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – present · 16 months · monthly snapshot

Change History

22 versions recorded
  1. Apr 2025 — Present [monthly]

    Terminated

    Status: Active Not RecruitingTerminated

  2. Sep 2024 — Apr 2025 [monthly]

    Active Not Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  4. Mar 2024 — Jul 2024 [monthly]

    Active Not Recruiting

  5. Aug 2023 — Mar 2024 [monthly]

    Active Not Recruiting

Show 17 earlier versions
  1. Feb 2023 — Aug 2023 [monthly]

    Active Not Recruiting

  2. Jul 2022 — Feb 2023 [monthly]

    Active Not Recruiting

  3. May 2022 — Jul 2022 [monthly]

    Active Not Recruiting

  4. Jan 2022 — May 2022 [monthly]

    Active Not Recruiting

  5. Dec 2021 — Jan 2022 [monthly]

    Active Not Recruiting

  6. Sep 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  7. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting

  8. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  9. Jun 2020 — Nov 2020 [monthly]

    Active Not Recruiting

  10. Jul 2019 — Jun 2020 [monthly]

    Active Not Recruiting

    Status: RecruitingActive Not Recruiting

  11. Dec 2018 — Jul 2019 [monthly]

    Recruiting

  12. Jun 2018 — Dec 2018 [monthly]

    Recruiting

  13. May 2018 — Jun 2018 [monthly]

    Recruiting

  14. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  15. Nov 2017 — Apr 2018 [monthly]

    Recruiting NA

  16. Aug 2017 — Nov 2017 [monthly]

    Recruiting NA

  17. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fred Hutchinson Cancer Center
  • Seattle Children's Hospital
  • University of Washington
Data source: Fred Hutchinson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations